NVO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Novo Nordisk A/S's cash flow from others for the three months ended in Mar. 2015 was $-518 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Mar. 2015 was $915 Mil.
Cash flow from others may include changes in working capital.
These are cash differences caused by the change of inventory, accounts payable, accounts receivable etc. For instance, if a company pays its suppliers slower, its cash position will build up faster. If a company receives payments from its customers slower, its account receivables will rise, and its cash position will grow more slowly (or even shrink).
Novo Nordisk A/S Cash Flow from Others for the trailing twelve months (TTM) ended in Mar. 2015 was 534.623867593 (Jun. 2014 ) + 868.985577506 (Sep. 2014 ) + 28.4999420059 (Dec. 2014 ) + -517.59143777 (Mar. 2015 ) = $915 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Novo Nordisk A/S Annual Data
|Cash Flow from Others||208||31||-102||243||458||363||139||-438||-379||516|
Novo Nordisk A/S Quarterly Data
|Cash Flow from Others||-911||506||145||-312||-155||-344||535||869||28||-518|